ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
128 hedge funds and large institutions have $447M invested in Array Biopharma Inc in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
128
Holders Change
+128
Holders Change %
–
% of All Funds
4.18%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
%
% of All Funds
0.13%
New
128
Increased
–
Reduced
–
Closed
–
Calls
$396K
Puts
$809K
Net Calls
-$413K
Net Calls Change
-$413K
Top Buyers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$50.5M |
| 2 |
DM
2
Deerfield Management
New York
|
$49.4M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$29.7M |
| 4 |
O
4
OrbiMed
New York
|
$22.1M |
| 5 |
RG
5
Redmile Group
San Francisco,
California
|
$21.7M |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GC
126
Globeflex Capital
San Diego,
California
| $1K | 267 | +267 | New |
|
127
Dimensional Fund Advisors
Austin,
Texas
| $1K | 300 | +300 | New |
|
|
PFG
128
Piershale Financial Group
Barrington,
Illinois
| $0 | 109 | +109 | New |
|